Indoco Remedies Ltd.

indoco.com

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented Pharma Company with presence in 55 countries. Indoco, a USD 165 million company, employs over 6000 people including 300 skilled scientists. The Company has 9 manufacturing facilities, out of which 6 are for finished dosage forms and 3 for APIs, supported by a state-of-the-art R&D centre at Rabale, Navi Mumbai. The facilities have been approved by various regulatory authorities such as USFDA, UK-MHRA, SUKL-Czech Republic, TGA-Australia, JAZMP- Slovenia, MCC-South Africa, NDA-Uganda, TFDA-Tanzania, SBD-Yemen, MOH-Ukraine, PPB-Kenya and FDA-Ghana.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

INSILICO MEDICINE ANNOUNCED STRATEGIC COLLABORATION WITH EQRX

Insilico Medicine | March 25, 2022

news image

A clinical-stage end-to-end artificial intelligence driven drug discovery firm, Insilico Medicine announced the formation of a strategic partnership with EQRx, a company dedicated to creating and delivering novel medications to patients at much-reduced costs. The cooperation will use Insilico's Pharma.AI technology to accelerate the design and creation of de novo small molecules and EQRx's clinical development and commercialization experience. In addition, EQRx and Insilic...

Read More

PHARMA TECH

EXCLUSIVE AGREEMENT: SPECIALISED THERAPEUTICS & ASCENDIS PHARMA TO DISTRIBUTE THREE ENDOCRINOLOGY THERAPIES IN AUSTRALIA & SELECT SE ASIA COUNTRIES

PR Newswire | January 08, 2024

news image

Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has added three new endocrinology therapies to its specialist portfolio, following an exclusive distribution agreement with Danish company Ascendis Pharma A/S. Under the terms of the agreement, ST will commercialise Ascendis Pharma's weekly injectable paediatric human growth hormone treatment SKYTROFA (lonapegsomatropin), hypoparathyroidism treatment YORVIPATH (palopegteriparatide) and investiga...

Read More

Pharmacy Market

KONEKSA LAUNCHES ACADEMIC COLLABORATION PROGRAM FOR PARKINSON’S DISEASE

Businesswire | August 18, 2023

news image

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs. The first collaboration of the KAPP-PD program, with Oregon Health & Science University (OHSU), enables the inclusion of app-and actigraphy-based digital measures and electronic patient reported outcome (...

Read More

Practice Management

AVKARE BOTTLES MIX VIAGRA GENERICS WITH ANTIDEPRESSANT, TRIGGERING RECALL

AvKARE | December 15, 2020

news image

A conventional drugmaker with a Rolodex loaded with government customers is pulling an energizer and an erectile brokenness medications after the two were bundled together in similar containers. Pulaski, Tennessee-based AvKARE reviewed one parcel of sildenafil 100-mg tablets and one parcel of trazodone 100-mg tablets after the items were stirred up by an outsider bundling provider, the organization said before the end of last week. The jugs had just been delivered to drug stores.<...

Read More
news image

Pharmacy Market

INSILICO MEDICINE ANNOUNCED STRATEGIC COLLABORATION WITH EQRX

Insilico Medicine | March 25, 2022

A clinical-stage end-to-end artificial intelligence driven drug discovery firm, Insilico Medicine announced the formation of a strategic partnership with EQRx, a company dedicated to creating and delivering novel medications to patients at much-reduced costs. The cooperation will use Insilico's Pharma.AI technology to accelerate the design and creation of de novo small molecules and EQRx's clinical development and commercialization experience. In addition, EQRx and Insilic...

Read More
news image

PHARMA TECH

EXCLUSIVE AGREEMENT: SPECIALISED THERAPEUTICS & ASCENDIS PHARMA TO DISTRIBUTE THREE ENDOCRINOLOGY THERAPIES IN AUSTRALIA & SELECT SE ASIA COUNTRIES

PR Newswire | January 08, 2024

Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has added three new endocrinology therapies to its specialist portfolio, following an exclusive distribution agreement with Danish company Ascendis Pharma A/S. Under the terms of the agreement, ST will commercialise Ascendis Pharma's weekly injectable paediatric human growth hormone treatment SKYTROFA (lonapegsomatropin), hypoparathyroidism treatment YORVIPATH (palopegteriparatide) and investiga...

Read More
news image

Pharmacy Market

KONEKSA LAUNCHES ACADEMIC COLLABORATION PROGRAM FOR PARKINSON’S DISEASE

Businesswire | August 18, 2023

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs. The first collaboration of the KAPP-PD program, with Oregon Health & Science University (OHSU), enables the inclusion of app-and actigraphy-based digital measures and electronic patient reported outcome (...

Read More
news image

Practice Management

AVKARE BOTTLES MIX VIAGRA GENERICS WITH ANTIDEPRESSANT, TRIGGERING RECALL

AvKARE | December 15, 2020

A conventional drugmaker with a Rolodex loaded with government customers is pulling an energizer and an erectile brokenness medications after the two were bundled together in similar containers. Pulaski, Tennessee-based AvKARE reviewed one parcel of sildenafil 100-mg tablets and one parcel of trazodone 100-mg tablets after the items were stirred up by an outsider bundling provider, the organization said before the end of last week. The jugs had just been delivered to drug stores.<...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us